Back to mobile site

More on NKTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.9 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nkarta (NQ:NKTX)
Delayed: 3.23 +0.31 (10.62%)
Prev. Close $2.92  
Open$2.86 
52 Wk High$ 
52 Wk Low$ 
Day High$3.30 
Day Low$2.80 
P/E N/A  
EPS$ 
Volume1,468,714 

Friends, Peers and Foes (?): FATE, GTBP, IBRX, IOVA, CMPX (more...)

Sep 8, 2026 07:00 AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Aug 14, 2026 08:10 AM Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses
Aug 11, 2026 06:51 AM Nkarta Inc. (NKTX) PT Lowered to $14 at H.C. Wainwright
Aug 10, 2026 06:18 PM Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c
Aug 10, 2026 04:24 PM Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 10, 2026 04:20 PM Form 10-Q Nkarta, Inc. For: Jun 30
Aug 10, 2026 04:13 PM Form 8-K Nkarta, Inc. For: Aug 10
Jul 23, 2026 01:30 AM Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Jun 26, 2026 08:45 AM Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 23, 2026 05:43 AM TD Cowen Starts Nkarta Inc. (NKTX) at Buy
View All Articles

Entities mentioned with NKTX

View All Entities